Author(s) |
(Date) |
Paper Title |
Citation |
Model Type |
Applications |
Full Text |
Liao X, et al. Mouse over for full list |
(2021) | Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha. | Bioengineered 12(2):10821-10834 | |||
Chen YH, et al. Mouse over for full list |
(2022) | Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases. | Arthritis Res Ther 24(1):27 | |||
Beckford-Vera DR, et al. Mouse over for full list |
(2020) | PET/CT Imaging of Human TNFα Using [Zr]Certolizumab Pegol in a Transgenic Preclinical Model of Rheumatoid Arthritis. | Mol Imaging Biol 22(1):105-114 | |||
Gorth DJ, et al. Mouse over for full list |
(2020) | Differential Effect of Long-Term Systemic Exposure of TNFα on Health of the Annulus Fibrosus and Nucleus Pulposus of the Intervertebral Disc. | J Bone Miner Res 35(4):725-737 | |||
Kishimoto TK, et al. Mouse over for full list |
(2016) | Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles. | Nat Nanotechnol 11(10):890-899 | |||
Lu YC, et al. Mouse over for full list |
(2019) | Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. | PLoS Biol. 17(6):e3000286 | Rheumatoid Arthritis | ||
Velasco-Velázquez MA, et al. Mouse over for full list |
(2017) | Extensive preclinical evaluation of an infliximab biosimilar candidate. | Eur J Pharm Sci 102:35-45 | |||
Ochi S, et al. Mouse over for full list |
(2007) | Pathological role of osteoclast costimulation in arthritis-induced bone loss. | Proc. Natl. Acad. Sci. U.S.A. 104(27):11394-9 | |||
Hayward MD, et al. Mouse over for full list |
(2007) | An extensive phenotypic characterization of the hTNFalpha transgenic mice. | BMC Physiol. 7:13 | |||
Gilbert LC, et al. Mouse over for full list |
(2013) | Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts. | Bone 56(1):174-83 | |||
Ghosh S, et al. Mouse over for full list |
(2010) | Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha. | Am. J. Pathol. 176(3):1484-93 | |||
Delavallée L, et al. Mouse over for full list |
(2009) | Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis. | Arthritis Res. Ther. 11(6):R195 | |||
Delavallée L, et al. Mouse over for full list |
(2008) | Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. | Ann. Rheum. Dis. 67(9):1332-8 | |||
Charles JF, et al. Mouse over for full list |
(2012) | Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. | J. Clin. Invest. 122(12):4592-605 | |||
Burri L, et al. Mouse over for full list |
(2011) | Tetradecylthioacetic acid increases hepatic mitochondrial β-oxidation and alters fatty acid composition in a mouse model of chronic inflammation. | Lipids 46(8):679-89 | |||
Bjørndal B, et al. Mouse over for full list |
(2012) | Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. | Metab. Clin. Exp. 61(10):1461-72 | |||
Bjørndal B, et al. Mouse over for full list |
(2012) | Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNFα. | Eur J Nutr 51(6):741-53 | |||
Bjørndal B, et al. Mouse over for full list |
(2013) | A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation. | Lipids Health Dis 12:143 | |||
Biton J, et al. Mouse over for full list |
(2011) | Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. | J. Immunol. 186(7):3899-910 |
Welcome! Tell us a little about yourself